Sinus Severe

NDC 70677-1005 · STRATEGIC SOURCING SERVICES LLC

Generic nameACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE

Dosage formTABLET, COATED

RouteORAL

Active ingredient(s)ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE

Strength325; 200; 5 mg/1; mg/1; mg/1

Pharmacologic classAdrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]

Marketing categoryOTC MONOGRAPH DRUG

Packages

70677-1005-1 — 2 BLISTER PACK in 1 CARTON (70677-1005-1) / 12 TABLET, COATED in 1 BLISTER PACK

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

70518-4467 — Butalbital, Acetaminophen, and Caffeine, 70518-4601 — BUTALBITAL, ACETAMINOPHEN AND CAFFEINE, 70594-063 — PHENYLEPHRINE HYDROCHLORIDE, 70594-064 — PHENYLEPHRINE HYDROCHLORIDE, 70594-065 — PHENYLEPHRINE HYDROCHLORIDE, 70677-0081 — Acetaminophen, Diphenhydramine HCL, 70677-0101 — Brompheniramine maleate, Phenylephrine HCl, 70677-0117 — Acetaminophen, 70677-0121 — Brompheniramine maleate, Dextromethorphan HBr, Phenylephrine HCl, 70677-1004 — ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, and PHENYLEPHRINE HYDROCHLORIDE, 70677-1011 — Guaifenesin and Pseudoephedrine HCL, 70677-1013 — Guaifenesin, 70677-1027 — acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride, 70677-1029 — acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride, 70677-1030 — acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride, 70677-1031 — acetaminophen, dextromethorphan Hbr, Phenylephrine HCl, 70677-1032 — Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, 70677-1033 — Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine succinate, 70677-1035 — dextromethorphan hydrobromide, guaifenesin, 70677-1036 — Dextromethorphan HBr, Guaifenesin, +4982 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels